首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1629270

照護端傳染病檢測市場，按技術、按疾病、按最終用戶、按國家和地區分類 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Point of Care Infectious Disease Testing Market, By Technology, By Disease, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年11月02日 | 出版商:

AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

報告要點

2023 年，即時傳染病檢測市場規模為 114.0943 億美元，2024 年至 2032 年複合年成長率為 4.69%。

即時傳染病檢測市場-市場動態

傳染病發病率的上升預計將推動市場的成長。

隨著流感、COVID-19、HIV、肝炎和性傳染病等傳染病發病率的上升，對快速且易於使用的檢測解決方案的需求也增加。 POC 測試可及時提供結果，有助於立即做出治療決定。根據國家生物技術資訊中心的數據，傳染病仍然是全世界發病和死亡的主要原因之一，全世界每年有超過 5,200 萬人 (33%) 死亡。此外，對快速檢測的需求不斷成長可能為市場創造成長機會。然而，對某些 POC 測試的準確性和可靠性的擔憂可能會阻礙市場成長。

即時護理傳染病檢測市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 4.69% 左右的複合年成長率成長

基於技術細分，預計分子診斷將在 2023 年呈現最大市場佔有率

根據疾病細分，COVID-19 是 2023 年的主導類型

根據最終用戶細分，診所是 2023 年的主導類型

按地區分類，北美是 2023 年的主要收入來源

照護端傳染病檢測市場-細分分析：

全球照護端傳染病檢測市場根據技術、疾病、最終用戶和地區進行細分。

根據技術，市場分為三個部分：側流免疫分析、凝集測試、流通測試/免疫濃縮分析、分子診斷和其他。其中，分子診斷在市場上佔據領先地位。這部分強調了在患者照護端或附近進行快速、精確的傳染病檢測的重要性，採用複雜的分子方法，如聚合酶鏈反應 (PCR) 和下一代定序 (NGS)。

市場依疾病分為兩大類：HIV POC、艱難梭菌 POC、HBV POC、肺炎或鏈球菌相關感染、呼吸道合胞病毒 (RSV) POC、HPV POC、流感/流感 POC、HCV POC、MRSA POC 、結核病及抗藥性結核病POC、HSV POC、COVID-19 等。 COVID-19 細分市場在市場上佔據主導地位。這場大流行凸顯了迅速而精確的檢測的迫切必要性，以減輕病毒的傳播並加強患者管理。

根據用戶，市場分為兩個部分：診所、醫院、家庭和自我測試、輔助生活醫療設施和實驗室。診所在市場上佔據主導地位。這些設施包括初級護理、緊急護理和專科診所，能夠進行現場測試，從而促進患者管理方面的及時決策，從而獲得顯著優勢。

即時護理傳染病檢測市場 - 地理洞察

市場地域廣闊，涵蓋北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些領域根據對商業活動做出貢獻的國家進一步細分。北美是市場成長的領先地區，這主要是由於擴大採用先進的照護端診斷來識別各種傳染病。該地區受益於強大的醫療保健基礎設施，促進創新診斷技術的整合。醫院、診所和實驗室正在逐步實施即時檢測解決方案，以改善病患照護。據美國國家生物技術資訊中心稱，截至 2020 年 7 月 13 日，美國已有超過 330 萬居民被診斷出患有 2019 年冠狀病毒病（COVID-19），報告死亡人數超過 135,000 人。在家庭醫療保健服務需求不斷成長的推動下，歐洲成為市場成長的第二大地區。

照護端傳染病檢測市場-競爭格局：

即時照護 (POC) 傳染病檢測市場的特徵是眾多利害關係人之間的激烈競爭，而對快速、精確的診斷解決方案的需求不斷成長，加劇了這種競爭。許多公司正在與醫療保健組織和科技企業建立策略聯盟，以提高他們的測試能力並擴大他們的市場佔有率。這種競爭環境是動態的、不斷變化的。隨著快速、準確診斷的必要性不斷升級，公司必須保持敏捷性，以應對不斷變化的市場需求和技術創新。

市場片段
- 照護端傳染病檢測市場技術片段
- 照護端傳染病檢測市場片段（依疾病）
- 最終使用者的照護端傳染病檢測市場片段
- 按國家/地區分類的照護端傳染病檢測市場片段
- 按地區分類的照護端傳染病檢測市場片段
競爭洞察

第 3 章：即時護理傳染病檢測主要市場趨勢

即時護理傳染病檢測市場促進因素
- 市場促進因素的影響分析
即時傳染病檢測市場限制
- 市場限制影響分析
即時護理傳染病檢測市場機會
即時護理傳染病檢測市場未來趨勢

第 4 章：即時傳染病檢測產業研究

PEST分析
波特五力分析
成長前景圖
規範架構分析

第 5 章：即時護理傳染病檢測市場：COVID-19 影響分析

COVID-19 之前的影響分析
COVID-19 後影響分析
- 表現最佳的市場區隔
- 邊際成長市場區隔
- 最寬鬆的市場區隔
- 邊際損失市場區隔

第 6 章：即時傳染病檢測市場格局

2023 年照護端傳染病檢測市佔率分析
按主要製造商分類的故障數據
- 既有參與者分析
- 新興參與者分析

第 7 章：即時傳染病檢測市場 - 依技術分類

概述
- 按技術分類的細分市場佔有率分析
- 側流免疫分析
- 凝集試驗
- 流通測試/免疫濃度測定
- 分子診斷
- 其他

第 8 章：即時傳染病檢測市場 - 按疾病分類

概述
- 按疾病分類的細分市場佔有率分析
- 愛滋病毒POC
- 艱難梭菌 POC
- 乙肝病毒POC
- 肺炎或鏈球菌相關感染
- 呼吸道合胞病毒 (RSV) POC
- HPV POC
- 流感/流感 POC
- 丙型肝炎病毒POC
- 耐甲氧西林金黃色葡萄球菌POC
- 結核病和抗藥性結核病 POC
- 單純皰疹病毒POC
- 新冠肺炎
- 其他

第 9 章：照護端傳染病檢測市場 - 按最終用戶

概述
- 按最終用戶分類的細分市場佔有率分析
- 診所
- 醫院
- 家庭和自我測試
- 輔助生活醫療設施
- 實驗室

第 10 章：即時護理傳染病檢測市場 - 按地理位置

介紹
- 按地理位置分類的細分市場佔有率分析
北美洲
- 概述
- 北美照護端傳染病檢測主要製造商
- 北美市場規模和預測（按國家）
- 北美市場規模和預測（按技術）
- 北美市場規模與預測（按疾病）
- 北美市場規模和預測（按最終用戶）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲床邊傳染病檢測主要製造商
- 歐洲市場規模和預測（按國家）
- 歐洲市場規模與預測（按技術）
- 歐洲市場規模與預測（按疾病）
- 歐洲市場規模和預測（按最終用戶）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區照護端傳染病檢測主要製造商
- 亞太地區市場規模與預測（按國家）
- 亞太地區市場規模與預測（按技術）
- 亞太地區市場規模與預測（按疾病）
- 亞太地區市場規模和預測（按最終用戶）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲即時傳染病檢測主要製造商
- 拉丁美洲市場規模與預測（按國家）
- 拉丁美洲市場規模與預測（按技術）
- 拉丁美洲市場規模與預測（按疾病）
- 拉丁美洲市場規模和預測（按最終用戶）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 照護端傳染病檢測中東和非洲的主要製造商
- 中東和非洲市場規模及預測（按國家）
- 中東和非洲市場規模及預測（按技術）
- 中東和非洲市場規模及預測（按疾病）
- 中東和非洲市場規模和預測（按最終用戶）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分

第 11 章：主要供應商分析 - 即時傳染病檢測產業

競爭儀表板
公司簡介
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers
- Becton, Dickinson & Company
- Abbott
- Thermo Fisher Scientific Inc
- Chembio Diagnostics Inc.
- Trinity Biotech
- Cardinal Health
- Quest Diagnostics Incorporated
- Bio-Rad Laboratories Inc.
- bioMerieux SA
- Sight Diagnostics Ltd.
- Gene POC
- Trivitron Healthcare
- OJ-Bio Ltd.
- Ortho-Clinical Diagnostics.
- Others

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV4443

REPORT HIGHLIGHT

Point of Care Infectious Disease Testing Market size was valued at USD 11,409.43 million in 2023, expanding at a CAGR of 4.69% from 2024 to 2032.

Point of Care Infectious Disease Testing (POC IDT) refers to diagnostic tests conducted at or near the site of patient care, allowing for the rapid detection of infectious diseases. This approach enables healthcare providers to obtain immediate results, facilitating timely diagnosis and treatment decisions without the need to send samples to a central laboratory. POC IDT represents a significant progression in healthcare, offering rapid and accessible diagnostic solutions that enhance patient care and contribute positively to public health outcomes.

Point of Care Infectious Disease Testing Market- Market Dynamics

Rising Incidence of Infectious Diseases is expected to drive the growth of the market.

As the prevalence of infectious diseases such as influenza, COVID-19, HIV, hepatitis, and STIs rises, the demand for rapid and accessible testing solutions increases. POC tests provide timely results that facilitate immediate treatment decisions. According to the National Center for Biotechnology Information, Infectious diseases remain one of the leading causes of morbidity and mortality around the world accounting for more than 52 million (33%) annual deaths worldwide. Furthermore, Growing Demand for Rapid Testing may create growth opportunities for the market. However, Concerns about the accuracy and reliability of some POC tests can hinder market growth.

Point of Care Infectious Disease Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.69% over the forecast period (2024-2032)

Based on Technology segmentation, Molecular Diagnostics was predicted to show maximum market share in the year 2023

Based on Disease segmentation, COVID-19 was the leading type in 2023

Based on End-User segmentation, Clinics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Point of Care Infectious Disease Testing Market- Segmentation Analysis:

The Global Point of Care Infectious Disease Testing Market is segmented based on Technology, Disease, End-User, and Region.

The market is classified into three segments according to technology: Lateral Flow Immunoassay, Agglutination Test, Flow-through Test/Immunoconcentration Assay, Molecular Diagnostics, and Others. Among these, Molecular Diagnostics holds a leading position in the market. This segment emphasizes the importance of swift and precise testing for infectious diseases conducted at or near the point of patient care, employing sophisticated molecular methods such as polymerase chain reaction (PCR) and next-generation sequencing (NGS).

The market is classified into two primary categories based on diseases: HIV POC, Clostridium Difficile POC, HBV POC, pneumonia or Streptococcus-associated infections, Respiratory Syncytial Virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV POC, COVID-19, and others. The COVID-19 segment holds a dominant position in the market. The pandemic underscored the urgent necessity for swift and precise testing to mitigate the virus's spread and enhance patient management.

The market is categorized into two segments according to the Users: Clinics, Hospitals, Home and Self Testing, Assisted Living Healthcare Facilities, and Laboratories. Clinics hold a dominant position within the market. These facilities, which encompass primary care, urgent care, and specialty clinics, gain significant advantages from the capability to conduct tests on-site, facilitating prompt decision-making regarding patient management.

Point of Care Infectious Disease Testing Market- Geographical Insights

This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These areas are further segmented based on the countries contributing to business activities. North America is the leading region in market growth, primarily due to the rising adoption of advanced point-of-care diagnostics for identifying various infectious diseases. The region benefits from a robust healthcare infrastructure that facilitates the integration of innovative diagnostic technologies. Hospitals, clinics, and laboratories are progressively implementing point-of-care testing solutions to improve patient care. According to the National Center for Biotechnology Information, as of July 13, 2020, over 3.3 million residents in the United States have been diagnosed with coronavirus disease 2019 (COVID-19), with more than 135,000 fatalities reported. Europe ranks as the second-largest region for market growth, driven by an increasing demand for home healthcare services.

Point of Care Infectious Disease Testing Market- Competitive Landscape:

The market for point-of-care (POC) Infectious Disease Testing is marked by significant competition among numerous stakeholders, fueled by the increasing need for swift and precise diagnostic solutions. A variety of companies are engaging in strategic alliances with healthcare organizations and technology enterprises to improve their testing capabilities and broaden their market presence. This competitive environment is dynamic and evolving. As the necessity for rapid and accurate diagnostics escalates, companies must remain agile in responding to shifting market demands and technological innovations.

Recent Developments:

On July 29, 2024, Roche announced the successful completion of its acquisition of LumiraDx's Point of Care technology, having obtained all necessary antitrust and regulatory approvals. Roche will now proceed with the comprehensive integration of the innovative multi-assay point-of-care platform, along with the associated research and development, operational, and commercial facilities, into its global organization.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

F. Hoffmann-La Roche Ltd
Siemens Healthineers
Becton, Dickinson & Company
Abbott
Thermo Fisher Scientific Inc
Chembio Diagnostics Inc.
Trinity Biotech
Cardinal Health
Quest Diagnostics Incorporated
Bio-Rad Laboratories Inc.
bioMerieux SA
Sight Diagnostics Ltd.
Gene POC
Trivitron Healthcare
OJ-Bio Ltd.
Ortho-Clinical Diagnostics.
Others

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

Lateral Flow Immunoassay
Agglutination Test
Flow-through test/Immunoconcentration Assay
Molecular Diagnostics
Others

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET, BY DISEASE- MARKET ANALYSIS, 2019 - 2032

HIV POC
Clostridium Difficile POC
HBV POC
Pneumonia Or Streptococcus Associated Infections
Respiratory Syncytial Virus (RSV) POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB & Drug-resistant TB POC
HSV POC
COVID-19
Other

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Clinics
Hospitals
Home and Self Testing
Assisted Living Healthcare Facilities
Laboratory

GLOBAL POINT OF CARE INFECTIOUS DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Point of Care Infectious Disease Testing Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Point of Care Infectious Disease Testing Market Snippet by Technology
- 2.1.2. Point of Care Infectious Disease Testing Market Snippet by Disease
- 2.1.3. Point of Care Infectious Disease Testing Market Snippet by End-User
- 2.1.4. Point of Care Infectious Disease Testing Market Snippet by Country
- 2.1.5. Point of Care Infectious Disease Testing Market Snippet by Region
2.2. Competitive Insights

3. Point of Care Infectious Disease Testing Key Market Trends

3.1. Point of Care Infectious Disease Testing Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Point of Care Infectious Disease Testing Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Point of Care Infectious Disease Testing Market Opportunities
3.4. Point of Care Infectious Disease Testing Market Future Trends

4. Point of Care Infectious Disease Testing Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Point of Care Infectious Disease Testing Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Point of Care Infectious Disease Testing Market Landscape

6.1. Point of Care Infectious Disease Testing Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Point of Care Infectious Disease Testing Market - By Technology

7.1. Overview
- 7.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
- 7.1.2. Lateral Flow Immunoassay
- 7.1.3. Agglutination Test
- 7.1.4. Flow-through test/Immunoconcentration Assay
- 7.1.5. Molecular Diagnostics
- 7.1.6. Others

8. Point of Care Infectious Disease Testing Market - By Disease

8.1. Overview
- 8.1.1. Segment Share Analysis, By Disease, 2023 & 2032 (%)
- 8.1.2. HIV POC
- 8.1.3. Clostridium Difficile POC
- 8.1.4. HBV POC
- 8.1.5. Pneumonia Or Streptococcus Associated Infections
- 8.1.6. Respiratory Syncytial Virus (RSV) POC
- 8.1.7. HPV POC
- 8.1.8. Influenza/Flu POC
- 8.1.9. HCV POC
- 8.1.10. MRSA POC
- 8.1.11. TB & Drug-resistant TB POC
- 8.1.12. HSV POC
- 8.1.13. COVID-19
- 8.1.14. Other

9. Point of Care Infectious Disease Testing Market - By End-User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 9.1.2. Clinics
- 9.1.3. Hospitals
- 9.1.4. Home and Self Testing
- 9.1.5. Assisted Living Healthcare Facilities
- 9.1.6. Laboratory

10. Point of Care Infectious Disease Testing Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Point of Care Infectious Disease Testing Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Point of Care Infectious Disease Testing Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Point of Care Infectious Disease Testing Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Point of Care Infectious Disease Testing Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Point of Care Infectious Disease Testing Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Point of Care Infectious Disease Testing Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. F. Hoffmann-La Roche Ltd
- 11.2.2. Siemens Healthineers
- 11.2.3. Becton, Dickinson & Company
- 11.2.4. Abbott
- 11.2.5. Thermo Fisher Scientific Inc
- 11.2.6. Chembio Diagnostics Inc.
- 11.2.7. Trinity Biotech
- 11.2.8. Cardinal Health
- 11.2.9. Quest Diagnostics Incorporated
- 11.2.10. Bio-Rad Laboratories Inc.
- 11.2.11. bioMerieux SA
- 11.2.12. Sight Diagnostics Ltd.
- 11.2.13. Gene POC
- 11.2.14. Trivitron Healthcare
- 11.2.15. OJ-Bio Ltd.
- 11.2.16. Ortho-Clinical Diagnostics.
- 11.2.17. Others